Big Gain For Protalix BioTherapeutics, Inc.
Mon, Apr 04, 2022 at 05:30 PM
Protalix BioTherapeutics, Inc. (PLX:NYSEMKT) jumped higher at $1.49, representing a gain of 41.9%. The stock appeared on our News Catalysts scanner on Mon, Apr 04, 2022 at 09:07 AM in the 'BIOTECH' category. From Mon, Mar 21, 2022, the stock recorded 55.56% Up Days and 60.00% Green Days
The share price of the company has been moving sideways in recent weeks.
About Protalix BioTherapeutics, Inc. (PLX:NYSEMKT)
Protalix BioTherapeutics Inc is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression system, or ProCellEx.
Top 10 Gainers:
- GBS Inc. (GBS:NASDAQ), 67.95%
- Aterian Inc. (ATER:NASDAQ), 46.78%
- Protalix BioTherapeutics, Inc. (PLX:NYSEMKT), 41.9%
- IO Biotech Inc. (IOBT:NASDAQ), 33.16%
- VirnetX Holding Corp (VHC:NYSE), 31.33%
- Dingdong (Cayman) Limited American Depositary Shares (each two representing three) (DDL:NYSE), 28.77%
- BRC Inc. Class A (BRCC:NYSE), 28.72%
- Cognition Therapeutics Inc. (CGTX:NASDAQ), 28.08%
- Twitter, Inc. (TWTR:NYSE), 27.12%
- Jumia Technologies AG (JMIA:NYSE), 24.68%